{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:57:13Z","timestamp":1740149833628,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s12328-024-02077-9","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T16:16:32Z","timestamp":1733415392000},"page":"67-73","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A case of gastric\/duodenal diffuse large B cell lymphoma observed during the administration of tacrolimus\/azathioprine for dermatomyositis"],"prefix":"10.1007","volume":"18","author":[{"given":"Ayako","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6035-8755","authenticated-orcid":false,"given":"Ayumi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Harigai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoji","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsutoshi","family":"Tokushige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"2077_CR1","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1056\/NEJMe2209117","volume":"387","author":"A Anthony","year":"2022","unstructured":"Anthony A, Amato MD. Intravenous immune globulin therapy in dermatomyositis. N Engl J Med. 2022;387:1320\u20131.","journal-title":"N Engl J Med"},{"key":"2077_CR2","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.nmd.2010.03.011","volume":"20","author":"J Van de Vlekkert","year":"2010","unstructured":"Van de Vlekkert J, Hoogendijk JE, de Haan RJ, et al. Oral dexamethasone pulse therapy versus daily prednisolone in sub-acute onset myositis, a randomized clinical trial. Neuromuscul Disord. 2010;20:382\u20139.","journal-title":"Neuromuscul Disord"},{"key":"2077_CR3","volume":"8","author":"PA Gordon","year":"2012","unstructured":"Gordon PA, Winer JB, Hoogendijk JE, et al. Immunosuppressive and immunomodulatory treatment for dermatomyositis and polymyositis. Cochrane Database Syst Rev. 2012;8: CD003643.","journal-title":"Cochrane Database Syst Rev"},{"key":"2077_CR4","first-page":"2855","volume":"27","author":"KA Qushmaq","year":"2000","unstructured":"Qushmaq KA, Chalmers A, Esdaile JM. Cyclosporin A in the treatment of refractory adult polymyositis\/dermatomyositis: population based experience in 6 patients and literature review. J Rheumatol. 2000;27:2855\u20139.","journal-title":"J Rheumatol"},{"key":"2077_CR5","first-page":"1741","volume":"18","author":"MH Ellman","year":"1991","unstructured":"Ellman MH, Hurwitz H, Thomas C, Kozloff M. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol. 1991;18:1741\u20133.","journal-title":"J Rheumatol"},{"issue":"1","key":"2077_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14397595.2018.1521185","volume":"29","author":"H Kohsaka","year":"2019","unstructured":"Kohsaka H, Mimori T, Kanda T, et al. Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists. Mod Rheumatol. 2019;29(1):1\u201319.","journal-title":"Mod Rheumatol"},{"issue":"3","key":"2077_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3109\/s10165-008-0053-0","volume":"18","author":"A Komatsuda","year":"2008","unstructured":"Komatsuda A, Wakui H, Nimura T, Sawada K-I. Reversible infliximab-related lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis. Mod Rheumatol. 2008;18(3):315\u20138.","journal-title":"Mod Rheumatol"},{"issue":"2","key":"2077_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3960\/jslrt.19007","volume":"59","author":"M Tokuhira","year":"2019","unstructured":"Tokuhira M, Tamaru J-I, Kizaki M. Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders. J Clin Exp Hematopathol. 2019;59(2):72\u201392.","journal-title":"J Clin Exp Hematopathol"},{"key":"2077_CR9","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059\u201368.","journal-title":"J Clin Oncol"},{"key":"2077_CR10","unstructured":"Yasuo Suzuki et al. https:\/\/mhlw-grants.niph.go.jp\/system\/files\/report_pdf\/202013002A%20--buntan2_0.pdf"},{"key":"2077_CR11","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1097\/PAS.0000000000001271","volume":"43","author":"D Kurita","year":"2019","unstructured":"Kurita D, et al. Methotrexate-associated lymphoproliferative disorders in patients with rheumatoid arthritis: clinicopathologic features and prognostic factors. Am J Surg Pathol. 2019;43:869\u201384.","journal-title":"Am J Surg Pathol"},{"key":"2077_CR12","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1080\/10428194.2017.1369073","volume":"59","author":"M Tokuhira","year":"2018","unstructured":"Tokuhira M, et al. Clinicopathlogic investigation of methotrexate-induced lymphoproliferative disorders, with a focus on regression. Leuk Lymphoma. 2018;59:1143\u201352.","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"2077_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3960\/jslrt.52.211","volume":"52","author":"Y Sekiguchi","year":"2012","unstructured":"Sekiguchi Y, Shimada A, Imai H, et al. Epstein-Barr virus-negative, CD5-positive diffuse large B-cell lymphoma developing after treatment with oral tacrolimus for mixed connective tissue disease\u202f: a case report and review of the literature. J Clin Exp Hematopathol. 2012;52(3):211\u20138.","journal-title":"J Clin Exp Hematopathol"},{"key":"2077_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.06.2008.0038","author":"S Dubey","year":"2009","unstructured":"Dubey S, Adebajo AO. Lymphoproliferative disorder due to sulphasalazine. Case Reports. 2009. https:\/\/doi.org\/10.1136\/bcr.06.2008.0038. (Published online 2009 Mar 17).","journal-title":"Case Reports"},{"issue":"10","key":"2077_CR15","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.2169\/naika.100.2902","volume":"100","author":"Y Suzuki","year":"2011","unstructured":"Suzuki Y, Chinen N. Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant\/antirheumatic drugs; 1. Methotrexate. J Jpn Soc Intern Med. 2011;100(10):2902\u20139.","journal-title":"J Jpn Soc Intern Med"},{"issue":"19","key":"2077_CR16","doi-asserted-by":"publisher","first-page":"6777","DOI":"10.1002\/cam4.4198","volume":"10","author":"A Satou","year":"2021","unstructured":"Satou A, Nakamura S. EBV-positive B-cell lymphomas and lymphoproliferative disorders: review from the perspective of immune escape and immunodeficiency. Cancer Med. 2021;10(19):6777\u201385.","journal-title":"Cancer Med"},{"key":"2077_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/ejh.12116","volume":"91","author":"A Ichikawa","year":"2013","unstructured":"Ichikawa A, et al. Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histrogy, Epstein-Barr virus, and clonarity are important predictors of disease progression and regression. Eur J Haematol. 2013;91:20\u20138.","journal-title":"Eur J Haematol"},{"key":"2077_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/14397595.2021.1879362","volume":"32","author":"N Kuramoto","year":"2022","unstructured":"Kuramoto N, et al. Characteristics of rheumatoid arthritis with immunodeficiency-associated lymphoproliferative disorders to regress spontaneously by the withdrawal of methotrexate and their clinical course: a retrospective, multicenter, case-control study. Mod Rheumatol. 2022;32:24\u201331.","journal-title":"Mod Rheumatol"},{"issue":"4","key":"2077_CR19","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3899\/jrheum.140533","volume":"42","author":"A Hashimoto","year":"2015","unstructured":"Hashimoto A, Chiba N, Tsuno H, et al. Incidence of malignancy and the risk of lymphoma in Japanese patients with rheumatoid arthritis compared to the general population. J Rheumatol. 2015;42(4):564\u201371.","journal-title":"J Rheumatol"},{"key":"2077_CR20","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","volume":"374","author":"L Beaugerie","year":"2009","unstructured":"Beaugerie L, Brousse N, Bouvier AM, et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational study. Lancet. 2009;374:1617\u201325.","journal-title":"Lancet"},{"key":"2077_CR21","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.2169\/internalmedicine.2782-19","volume":"58","author":"S Toyama","year":"2019","unstructured":"Toyama S, Takatani A, Koga T, et al. Gastric perforation due to iatrogenic immunodeficiency-associated lymphoproliferative disorder during the treatment of rheumatoid arthritis. Intern Med. 2019;58:3331\u20136.","journal-title":"Intern Med"},{"key":"2077_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-060659","volume":"12","author":"Y Bai","year":"2022","unstructured":"Bai Y, He T, Zhang L, et al. Prognostic value of FOXP3+ regulatory T cells in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis. BMJ Open. 2022;12: e060659.","journal-title":"BMJ Open"},{"issue":"2","key":"2077_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1365-2036.2010.04330.x","volume":"32","author":"MA Smith","year":"2010","unstructured":"Smith MA, Irving PM, Marinaki AM, Sanderson JD. Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel disease. Aliment Pharmacol Ther. 2010;32(2):119\u201330.","journal-title":"Aliment Pharmacol Ther"},{"key":"2077_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/road098","author":"H Kameda","year":"2023","unstructured":"Kameda H, Yamaoka K, Yamanishi Y, et al. Japan College of Rheumatology guidance for the use of methotrexate in patients with rheumatoid arthritis: secondary publication. Mod Rheumaol. 2023. https:\/\/doi.org\/10.1093\/mr\/road098. (Online ahead of print).","journal-title":"Mod Rheumaol"},{"issue":"12","key":"2077_CR25","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1093\/ibd\/izy160","volume":"24","author":"U Mahadevan","year":"2018","unstructured":"Mahadevan U, Dubinsky MC, Su C, et al. Outcomes of pregnancies with maternal\/paternal exposure in the tofacitinib safety databases for ulcerative colitis. Inflamm Bowel Dis. 2018;24(12):2494\u2013500.","journal-title":"Inflamm Bowel Dis"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-024-02077-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-024-02077-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-024-02077-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T13:16:33Z","timestamp":1738329393000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-024-02077-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["2077"],"URL":"https:\/\/doi.org\/10.1007\/s12328-024-02077-9","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"24 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}